These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 26901113)
1. The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda. Ngabo F; Mvundura M; Gazley L; Gatera M; Rugambwa C; Kayonga E; Tuyishime Y; Niyibaho J; Mwenda JM; Donnen P; Lepage P; Binagwaho A; Atherly D PLoS One; 2016; 11(2):e0149805. PubMed ID: 26901113 [TBL] [Abstract][Full Text] [Related]
2. Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination. Rochanathimoke O; Riewpaiboon A; Tharmaphornpilas P; Jiamsiri S; Thavorncharoensap M; Postma MJ Vaccine; 2019 Jan; 37(4):587-594. PubMed ID: 30579755 [TBL] [Abstract][Full Text] [Related]
3. Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan. Chen KT; Fan SF; Tang RB; Huang YF; Lee PI; Chen PY; Tang CW; Chen HC Vaccine; 2007 May; 25(21):4266-72. PubMed ID: 17360079 [TBL] [Abstract][Full Text] [Related]
4. Can routinely collected national data on childhood morbidity and mortality from diarrhea be used to monitor health impact of rotavirus vaccination in Africa? Examination of pre-vaccine baseline data from Rwanda. Ngabo F; Gatera M; Karema C; Donnen P; Lepage P; Parashar UD; Tate JE; Mwenda JM; Rugambwa C; Binagwaho A Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S89-93. PubMed ID: 24343621 [TBL] [Abstract][Full Text] [Related]
5. Diarrhea hospitalization costs among children <5 years old in Madagascar. Burnett E; Rahajamanana VL; Raboba JL; Weldegebriel G; Vuo Masembe Y; Mwenda JM; Parashar UD; Tate JE; Robinson AL Vaccine; 2020 Nov; 38(47):7440-7444. PubMed ID: 33051040 [TBL] [Abstract][Full Text] [Related]
6. Cost estimates of diarrhea hospitalizations among children <5 years old in Zimbabwe. Mujuru HA; Burnett E; Nathoo KJ; Ticklay I; Gonah NA; Mukaratirwa A; Berejena C; Manangazira P; Rupfutse M; Chavers T; Weldegebriel GG; Mwenda JM; Parashar UD; Tate JE Vaccine; 2020 Oct; 38(43):6735-6740. PubMed ID: 32873405 [TBL] [Abstract][Full Text] [Related]
7. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan. Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826 [TBL] [Abstract][Full Text] [Related]
8. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169 [TBL] [Abstract][Full Text] [Related]
9. The economic burden of diarrheal disease in a tertiary level hospital, Gauteng, South Africa. MacIntyre UE; de Villiers FP J Infect Dis; 2010 Sep; 202 Suppl():S116-25. PubMed ID: 20684690 [TBL] [Abstract][Full Text] [Related]
10. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis. Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective. Smith ER; Rowlinson EE; Iniguez V; Etienne KA; Rivera R; Mamani N; Rheingans R; Patzi M; Halkyer P; Leon JS Vaccine; 2011 Sep; 29(38):6704-11. PubMed ID: 21624421 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160 [TBL] [Abstract][Full Text] [Related]
13. Disease and economic burden of rotavirus diarrhoea in India. Tate JE; Chitambar S; Esposito DH; Sarkar R; Gladstone B; Ramani S; Raghava MV; Sowmyanarayanan TV; Gandhe S; Arora R; Parashar UD; Kang G Vaccine; 2009 Nov; 27 Suppl 5():F18-24. PubMed ID: 19931713 [TBL] [Abstract][Full Text] [Related]
14. Projected cost-effectiveness of rotavirus vaccination for children in Asia. Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797 [TBL] [Abstract][Full Text] [Related]
15. Anticipating rotavirus vaccines--a pre-vaccine assessment of incidence and economic burden of rotavirus hospitalizations among children < 5 year of age in Libya, 2012-13. Alkoshi S; Leshem E; Parashar UD; Dahlui M BMC Public Health; 2015 Jan; 15():26. PubMed ID: 25616973 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of rotavirus vaccination in Turkey. Koksal T; Akelma AZ; Koksal AO; Kutukoglu I; Ozdemir O; Yuksel CN; Bozkaya D; Catal F; Sari S J Microbiol Immunol Infect; 2017 Oct; 50(5):693-699. PubMed ID: 27107612 [TBL] [Abstract][Full Text] [Related]
18. The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh. Ahmed S; Dorin F; Satter SM; Sarker AR; Sultana M; Gastanaduy PA; Parashar U; Tate JE; Heffelfinger JD; Gurley ES; Khan JAM Vaccine; 2021 Nov; 39(48):7082-7090. PubMed ID: 34756769 [TBL] [Abstract][Full Text] [Related]
19. Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam. Riewpaiboon A; Shin S; Le TP; Vu DT; Nguyen TH; Alexander N; Dang DA; BMC Public Health; 2016 Aug; 16(1):777. PubMed ID: 27514373 [TBL] [Abstract][Full Text] [Related]
20. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]